Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

VITRAKVI larotrectinib (as sulfate)100 mg hard capsule bottle (320238)

ARTG ID

320238

ARTG Name

VITRAKVI larotrectinib (as sulfate)100 mg hard capsule bottle

Sponsor

Bayer Australia Ltd

ARTG Date

September 7, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Bayer Australia Ltd

Sponsor Item Name

BAYER AUSTRALIA LTD

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02431-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02289-1

Active Ingredients

Ingredient Name

larotrectinib sulfate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy